India, Oct. 28 -- DexCom, Inc. (DXCM) announced that its Dexcom G7 15 Day continuous glucose monitoring (CGM) system will be available in Canada beginning in November for adults aged 18 and older living with diabetes.
The system offers up to 15.5 days of sensor wear, allowing users to go longer between sensor changes and experience fewer interruptions to daily routines.
It is authorized by Health Canada and features an overall mean absolute relative difference (MARD) of 8.0%, a measure of glucose-monitoring accuracy.
Dexcom G7 15 Day is designed to provide real-time glucose readings and includes features such as customizable alerts, remote glucose sharing with caregivers, and integration with the Dexcom Clarity app for reviewing glucose ...